Dedifferentiated malignant myoepithelioma of the parotid gland

Pathology International

Volumn 53, Issue 10, 2003, Pages 704-709

  Ogawa, Ikuko ^a   Nishida, Toshihiro ^b   Miyauchi, Mutsumi ^c   Sato, Sunao ^c   Takata, Takashi ^a,c  

^a HIROSHIMA UNIVERSITY HOSPITAL   (Japan)

^b CHUGOKU ROSAI HOSPITAL   (Japan)

^c HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Dedifferentiation; Malignant myoepithelioma; Salivary gland

Indexed keywords

ALPHA ACTIN; CYCLIN D1; CYTOKERATIN; GLIAL FIBRILLARY ACIDIC PROTEIN; PROTEIN P53; PROTEIN S100B; VIMENTIN;

ADULT; ARTICLE; CASE REPORT; CELL POPULATION; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DISEASE COURSE; FACIAL NERVE; GENETICS; HISTOLOGY; HUMAN; HUMAN TISSUE; MALE; MYOEPITHELIOMA; PAROTID GLAND CANCER; PATHOLOGY; PRIORITY JOURNAL; SALIVARY GLAND TUMOR; SPINDLE CELL; TUMOR CELL; UNDIFFERENTIATED CARCINOMA;

CELL TRANSFORMATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MYOEPITHELIOMA; NEOPLASM PROTEINS; NEOPLASM RECURRENCE, LOCAL; PAROTID GLAND; PAROTID NEOPLASMS; RADIOTHERAPY, ADJUVANT; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 0242574442     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1827.2003.01536.x     Document Type: Article

References (24)

1. Dahlin DC, Beabout JW. Dedifferentiation of low-grade chondrosarcomas. Cancer 1971; 28: 461-6.
2. Meis JM. 'Dedifferentiation' in bone and soft tissue tumors. A histological indicator of tumor progression. Pathol Ann 1991; 26: 37-62.
3. Stanley RJ, Weiland LH, Olsen KD, Pearson BW. Dedifferentiated acinic cell (acinous) carcinoma of the parotid gland. Otolaryngol Head Neck Surg 1988; 98: 155-61.
4. Nunes JFM, Fonseca I, Soares J. Helioid inclusions in dedifferentiated acinic cell carcinoma of the parotid gland. Ultrastruct Pathol 1996; 20: 443-9.
5. Henley JD, Geary WA, Jackson CL, Wu CD, Gnepp DR. Dedifferentiated acinic cell carcinoma of the parotid gland: a distinct rarely described entity. Hum Pathol 1997; 28: 869-73.
6. Di Palma S, Corletto V, Lavarino C, Birindelli S, Pilotti S. Unilateral aneuploid dedifferentiated acinic cell carcinoma associated with bilateral-low grade diploid acinic cell carcinoma of the parotid gland. Virchows Arch 1999; 434: 361-6.
7. Cheuk W, Chan JKC, Ngan RKC. Dedifferentiation in adenoid cystic carcinoma of salivary gland. An uncommon complication associated with an accelerated clinical course. Am J Surg Pathol 1999; 23: 465-72.
8. Moles MAG, Avila IR, Archilla AR. Dedifferentiation occurring in adenoid cystic carcinoma of the tongue. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999; 88: 177-80.
9. Chau Y-P, Hongyo T, Aozasa K, Chan JKC. Dedifferentiation of adenoid cystic carcinoma: report of a case implicating p53 gene mutation. Hum Pathol 2001; 32: 1403-7.
10. Pelkey TJ, Millis SE. Histologic transformation of polymorphous low-grade adenocarcinoma of salivary gland. Am J Clin Pathol 1999; 111: 785-91.
11. Alos L, Carrillo R, Ramos J et al. High-grade carcinoma compoment in epithelial-myoepithelial carcinoma of salivary glands. Clinicopathological, immunohistochemical and flow-cytometric study of three cases. Virchows Arch 1999; 434: 291-9.
12. Fonseca I. Dedifferentiation in salivary gland carcinomas. Am J Surg Pathol 2000; 24: 469-71.
13. Seifert G, Sobin LH. The World Health Organization's histological classification of salivary gland tumors. A commentary on the second edition. Cancer 1992; 70: 379-85.
14. Dardick I, Cavell S, Boivin M et al. Salivary gland myoepithelioma variants. Histological, ultrastructural, and immunocytological features. Virchows Arch A Pathol Anat Histopathol 1989; 416: 25-42.
15. Di Palma S, Guzzo M. Malignant myoepithelioma of salivary glands: clinicopathological features of ten cases. Virchows Arch A Pathol Anat Histopathol 1993; 423: 389-96.
16. Nagao T, Sugano I, Ishida Y et al. Salivary gland malignant myoepithelioma. A clinicopathologic and immunohistochemical study of ten cases. Cancer 1998; 83: 1292-9.
17. Savera AT, Solman A, Huvos AG, Klimstra DS. Myoepithelial carcinoma of the salivary glands. A clinicopathologic study of 25 patients. Am J Surg Pathol 2000; 24: 761-74.
18. Seifert G, Donath K. Hybrid tumours of salivary glands. Definition and classification of five cases. Eur J Cancer B Oral Oncol 1996; 32: 251-9.
19. Yamamoto Y, Virmani AK, Wistuba II et al. Loss of heterozygosity and microsatellite alterations in p53 and RB genes in adenoid cystic carcinoma of the salivary gland. Hum Pathol 1996; 27: 1204-10.
20. Kamio N. Coexpression of p53 and c-erbB-2 proteins is associated with histological type, tumor stage, and cell proliferation in malignant salivary gland tumours. Virchows Arch 1996; 428: 75-83.
21. Cerilli LA, Swartzbaugh JR, Saadut R et al. Analysis of chromosome 9p21 deletion and p16 gene mutation in salivary gland carcinomas. Hum Pathol 1999; 30: 1242-6.
22. Nagao T, Sugano I, Ishida Y et al. Basal cell adenocarcinoma of the salivary glands: comparison with basal cell adenoma through assessment of cell proliferation, apoptosis, and expression of p53 and bcl-2. Cancer 1998; 82: 439-47.
23. Takata T, Kudo Y, Zhao M et al. Reduced expression of p27kip1 protein in relation to salivary adenoid cystic carcinoma metastasis. Cancer 1999; 86: 928-35.
24. Shintani S, Mihara M, Nakahara Y et al. Infrequent alterations of RB pathway (Rb-p16INK4A-cyclin D1) in adenoid cystic carcinoma of salivary glands. Anticancer Res 2000; 20: 2169-75.